- The Daily Trade
- Posts
- Trump's Medicare Drug Pricing Shakeup 💊
Trump's Medicare Drug Pricing Shakeup 💊
Ryan Serkes
April 16, 2025
The
Daily Trade
FROM OUR PARTNER
Is this startup the next billion dollar buyout?
Imagine investing in Ring before its $1.2B buyout by Amazon
Or Nest, before Google's $3.2B acquisition.
By the time we hear about industry-changing companies, it’s usually too late. But right now, there’s a smart home startup making their way to homes in America. This tech startup is RYSE, and unlike Ring, you can still invest before their $1.90 round closes May 30.
Like how Ring disrupted home security, this company is revolutionizing smart blinds & shades.
With $10M+ in revenue, 200% YoY growth, and sold in 127 Best Buy stores, they are primed for massive expansion and forecast 5X in revenue this year.
Past performance is not indicative of future results. Email may contain forward-looking statements. See US Offering for details. Informational purposes only.
Hey Daily Traders,
President Trump's latest executive order targets Medicare drug pricing, aiming to extend the timeline for price negotiations of small molecule drugs. This move, part of a broader effort to reduce healthcare costs, could significantly impact the pharmaceutical sector, especially with potential tariffs on the horizon.
In a daring heist, thieves made off with $10 million in jewelry from a Los Angeles store by tunneling through a concrete wall, highlighting vulnerabilities in high-value retail security. Meanwhile, Venture Global LNG's Calcasieu Pass plant begins commercial operations, marking a milestone for the U.S. LNG industry despite ongoing arbitration issues with major customers.
Here's what's happening today:
- 🔥 Trump pushes for Medicare drug price changes.
- 💎 Burglars steal $10M from LA jewelry store.
- 📈 Venture Global LNG starts operations at Calcasieu Pass.
- 🌊 USA Rare Earth stock surges on Trump's metal stockpile plan.
- 🚀 BDTCOIN listed on MEXC, boosting digital finance.
Question
What are your thoughts on President Trump's executive order targeting Medicare drug pricing—do you believe it will effectively reduce healthcare costs, or is it more symbolic than substantial?
Reply to this email with your answer
Stock Market  President Donald Trump has signed an executive order directing his health department to collaborate with Congress to revamp the Medicare drug pricing law. This move aims to extend the timeline for price negotiations for small molecule drugs, aligning it with the 13-year wait for biotech drugs. The order seeks to reduce healthcare costs and comes after a national security report into the pharmaceutical industry, which could lead to sector-specific tariffs. The executive order cannot directly change the negotiation process, as it is outlined in legislation, but it instructs the Secretary of Health and Human Services to work with Congress on the matter. The order also calls for aligning Medicare payments with hospital rates and standardizing patient payment rates across locations. This initiative is part of a broader effort to reduce healthcare costs and improve access to medications for Medicare's 66 million beneficiaries. Key Takeaway
|
Real Estate  In a high-stakes burglary, thieves tunneled through a concrete wall to access a Los Angeles jewelry store, making off with at least $10 million worth of merchandise. The heist occurred at Love Jewels in downtown LA, where suspects drilled a hole from a neighboring property to gain entry. Security footage shows the burglars entering through the hole and later fleeing in a Chevy truck. The stolen items include watches, pendants, and gold chains, with estimates of the loss potentially reaching $20 million. The police are investigating the scene for fingerprints and DNA, while the store owner and employees grapple with the significant financial impact. This brazen theft highlights the vulnerabilities of high-value retail locations and the sophistication of modern criminal tactics. Key Takeaway
|
Stock Market  Venture Global LNG has officially commenced commercial operations at its Calcasieu Pass plant in Louisiana, concluding a lengthy commissioning process. The plant's operations are set to sell LNG to long-term customers at lower prices, shifting from test cargoes sold at higher spot prices. The company, now the second-largest LNG producer in the U.S., faced delays due to global events, including the pandemic and natural disasters. Despite the start of operations, ongoing arbitration cases with customers like Shell and BP persist, as they claim Venture Global delayed commissioning to benefit from higher spot prices. The company's stock price has seen a decline since its public listing, but the move to commercial operations may stabilize its market position. This development marks a significant milestone for Venture Global and the U.S. LNG export industry. Key Takeaway
|
Stock Market  Shares of USA Rare Earth surged following reports of President Trump's plan to stockpile critical deep-sea metals. The executive order aims to counter China's dominance in the battery minerals and rare earth supply chains. This initiative has caused a significant increase in USA Rare Earth's stock price, which had been declining prior to the announcement. The move highlights the strategic importance of securing rare earth metals for the U.S. economy and national security. As the U.S. seeks to reduce dependence on China for these critical resources, companies like USA Rare Earth stand to benefit from increased government focus and potential stockpiling efforts. This development underscores the geopolitical tensions surrounding resource acquisition and the strategic moves by nations to secure essential materials. Key Takeaway
|
Crypto  BDTCOIN, a gold-backed cryptocurrency, has been listed on MEXC, one of the leading global crypto exchanges. This listing marks a significant milestone for BDTCOIN's mission to enhance financial inclusion and cross-border transactions. The cryptocurrency combines the stability of physical gold with the transparency of blockchain technology, offering a unique proposition in the digital asset market. The listing on MEXC provides BDTCOIN with increased visibility and accessibility to a global audience, opening up new trading and investment opportunities. As gold-backed digital assets gain traction, BDTCOIN positions itself as a frontrunner in this emerging market, aiming to empower underserved communities worldwide. This development highlights the growing trend of asset-backed cryptocurrencies and their potential to revolutionize the financial landscape. Key Takeaway
|
Today's Technical Analysis
RSI Sell | MFI Hold | WillR Sell | AO Sell |
CCI Sell | BBANDS Hold | ULTOSC Sell | STOCH Sell |
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Hold | STOCH Hold |
RSI Buy | MFI Buy | WillR Buy | AO Buy |
CCI Buy | BBANDS Hold | ULTOSC Hold | STOCH Hold |
RSI Sell | MFI Sell | WillR Sell | AO Hold |
CCI Sell | BBANDS Sell | ULTOSC Hold | STOCH Hold |
You might also like…
We’re always looking for opportunities to bring our readers more value so we’ve partnered with a handful of companies that we think you might enjoy.
If you have suggestions for companies we should partner with, let us know and we’ll reach out to them.
Do you have an idea for a new website or mobile app?
Under the leadership of tech entrepreneurs, Modern Launch develops software applications from scratch.
Mention The Daily Trade & get up to 20% off
Are you looking for your next real estate investment?
Every day, Labrador scans the MLS and runs a cash-flow analysis on every property to deliver only the highest ROI opportunities.
Do you want to try the best wines?
Get weekly wine recommendations from top sommeliers at Pour Decisions.
Thanks for Reading!
Have ideas to improve our newsletter?
Let us know
Want to reach our readers?
Become a partner
Was this email forwarded to you?
Subscribe here
How can we improve our newsletter's content?Your feedback is really important to us. We would really appreciate if you'd take a moment to let us know how we can bring you more value. |
Let’s stay in touch!
Thank you for reading today’s edition of The Daily Trade.
Let’s connect on LinkedIn!
-Ryan Serkes
Subscribe here if this email was forwarded to you!
Technical Indicator Information
Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30
Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20
Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80
Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75
Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal
Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20
Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100
Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band
Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price
Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0
Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30
Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI
Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25
Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.
Disclaimers
The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.
Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.